Table 1

Mini-review series on cancer-associated thrombotic disease

AuthorsAffiliationsReview title
Jasmijn F. Timp,1 Sigrid K. Braekkan,2 Henri H. Versteeg,1 and Suzanne C. Cannegieter1 1Leiden University Medical Center; 2University of Tromsø Epidemiology of cancer-associated venous thrombosis 
Julia E. Geddings and Nigel Mackman University of North Carolina Tumor-derived tissue factor–positive microparticles and venous thrombosis in cancer patients 
Ingrid Pabinger, Johannes Thaler, and Cihan Ay Medical University of Vienna Biomarkers for prediction of venous thromboembolism in cancer 
Tiziano Barbui, Guido Finazzi, and Anna Falanga Hospital Papa Giovanni XXIII Myeloproliferative neoplasms and thrombosis 
Agnes Y. Y. Lee and Erica A. Peterson University of British Columbia Treatment of cancer-associated thrombosis 
AuthorsAffiliationsReview title
Jasmijn F. Timp,1 Sigrid K. Braekkan,2 Henri H. Versteeg,1 and Suzanne C. Cannegieter1 1Leiden University Medical Center; 2University of Tromsø Epidemiology of cancer-associated venous thrombosis 
Julia E. Geddings and Nigel Mackman University of North Carolina Tumor-derived tissue factor–positive microparticles and venous thrombosis in cancer patients 
Ingrid Pabinger, Johannes Thaler, and Cihan Ay Medical University of Vienna Biomarkers for prediction of venous thromboembolism in cancer 
Tiziano Barbui, Guido Finazzi, and Anna Falanga Hospital Papa Giovanni XXIII Myeloproliferative neoplasms and thrombosis 
Agnes Y. Y. Lee and Erica A. Peterson University of British Columbia Treatment of cancer-associated thrombosis 

or Create an Account

Close Modal
Close Modal